These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15127242)

  • 1. The choice of the correct imaging modality in breast cancer management.
    Bombardieri E; Gianni L
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S179-86. PubMed ID: 15127242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art of current modalities for the diagnosis of breast lesions.
    Di Maggio C
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S56-69. PubMed ID: 15085294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of the breast.
    Birjawi G; El Zein Y
    J Med Liban; 2009; 57(1):47-54. PubMed ID: 19459577
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the diagnostic methods on the therapeutic strategies.
    Greco M; Agresti R; Giovanazzi R
    Q J Nucl Med; 1998 Mar; 42(1):66-80. PubMed ID: 9646647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening, imaging, and image-guided biopsy techniques for breast cancer.
    Smetherman DH
    Surg Clin North Am; 2013 Apr; 93(2):309-27. PubMed ID: 23464688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages and limitations of FDG PET in the follow-up of breast cancer.
    Lind P; Igerc I; Beyer T; Reinprecht P; Hausegger K
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S125-34. PubMed ID: 15085295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.
    Buscombe JR; Holloway B; Roche N; Bombardieri E
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):109-18. PubMed ID: 15243412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on detection of sentinel lymph nodes in patients with breast cancer.
    Aarsvold JN; Alazraki NP
    Semin Nucl Med; 2005 Apr; 35(2):116-28. PubMed ID: 15765374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions.
    Scheidhauer K; Walter C; Seemann MD
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S70-9. PubMed ID: 15133634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of the assessment of tumor extent in the breast using multiple image modalities.
    Zeggelink WF; Deurloo EE; Bartelink H; Rutgers EJ; Gilhuijs KG
    Med Phys; 2003 Nov; 30(11):2919-26. PubMed ID: 14655939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening: clinical, radiologic, and biochemical.
    Feldman ED; Oppong BA; Willey SC
    Clin Obstet Gynecol; 2012 Sep; 55(3):662-70. PubMed ID: 22828098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of Nonpalpable Breast Cancer in Premenopausal Women].
    Nudnov NV; Novikova EV
    Vestn Rentgenol Radiol; 2017; (1):5-16. PubMed ID: 30247855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging: the evolution of breast imaging.
    Heywang-Köbrunner SH; Hacker A; Sedlacek S
    Breast; 2013 Aug; 22 Suppl 2():S77-82. PubMed ID: 24074797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: short-term results of a pilot study in 40-49-year-old women.
    Venturini E; Losio C; Panizza P; Rodighiero MG; Fedele I; Tacchini S; Schiani E; Ravelli S; Cristel G; Panzeri MM; De Cobelli F; Del Maschio A
    Radiology; 2013 Aug; 268(2):347-55. PubMed ID: 23579052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New trends and novel possibilities in the diagnostic imaging of breast cancer].
    Bidlek M; Kovács E; Fehér K; Gõdény M
    Magy Onkol; 2015 Mar; 59(1):44-55. PubMed ID: 25763913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of BI-RADS to interpret magnetic resonance mammography for breast cancer].
    Kharuzhyk SA; Shimanets SV; Karman AV; Shapoval EV
    Vestn Rentgenol Radiol; 2014; (4):46-59. PubMed ID: 25775888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of breast MRI in planning the surgical treatment of breast cancer.
    Duygulu G; Oktay A; Bilgen IG; Kapkaç M; Zekioğlu O
    Diagn Interv Radiol; 2012; 18(5):460-7. PubMed ID: 22581712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic imaging of lobular carcinoma of the breast: mammographic, ultrasonographic and MR findings].
    Bazzocchi M; Facecchia I; Zuiani C; Puglisi F; Di Loreto C; Smania S
    Radiol Med; 2000 Dec; 100(6):436-43. PubMed ID: 11307504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.